HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

K Haruma Selected Research

K Haruma Research Topics

Disease

12Neoplasms (Cancer)
07/2002 - 01/2000
7Carcinoma (Carcinomatosis)
05/2006 - 07/2000
7Gastritis
06/2005 - 03/2000
7Neoplasm Metastasis (Metastasis)
07/2002 - 01/2000
6Infection
04/2010 - 03/2000
6Colorectal Neoplasms (Colorectal Cancer)
11/2001 - 01/2000
5Stomach Neoplasms (Stomach Cancer)
10/2013 - 07/2000
4Dyspepsia (Indigestion)
10/2013 - 08/2000
4Peptic Ulcer (Peptic Ulcers)
06/2005 - 07/2003
3Duodenogastric Reflux
06/2012 - 01/2001
3Ulcerative Colitis
06/2007 - 08/2000
3Atrophy
06/2005 - 03/2002
2Diarrhea
01/2015 - 08/2000
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
06/2007 - 08/2000
2Ulcer
04/2004 - 08/2000
2Adenoma (Adenomas)
10/2002 - 01/2000
2Microsatellite Instability
11/2001 - 03/2001
2Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
03/2001 - 03/2001
1Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
01/2015
1Esophagitis
07/2012
1Heartburn (Pyrosis)
07/2012
1Stomach Ulcer (Gastric Ulcer)
04/2010
1Skin Diseases
12/2009
1Crohn Disease (Crohn's Disease)
06/2007
1Hemorrhage
06/2005
1Ischemic Colitis
04/2004
1Anoxia (Hypoxia)
07/2003
1Inflammation
07/2003
1Gastroesophageal Reflux (GERD)
06/2003
1Polyps
10/2002
1Carcinoma in Situ
10/2002
1Metaplasia
08/2002
1Atrophic Gastritis
03/2002
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2001
1Postcholecystectomy Syndrome (Sump Syndrome)
08/2001
1Lymphoma (Lymphomas)
06/2001
1Peptic Esophagitis (Reflux Esophagitis)
05/2001
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell)
03/2001

Drug/Important Bio-Agent (IBA)

6Pepsinogen A (Pepsinogen)IBA
10/2013 - 08/2000
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2002 - 07/2000
4GastrinsIBA
06/2004 - 03/2000
4Messenger RNA (mRNA)IBA
07/2002 - 07/2000
3Biological Markers (Surrogate Marker)IBA
01/2015 - 06/2004
3Proton Pump InhibitorsIBA
10/2013 - 06/2003
3Omeprazole (Esomeprazole)FDA LinkGeneric
07/2012 - 09/2003
3AntralIBA
06/2012 - 09/2000
3rebamipideIBA
07/2003 - 08/2000
3Telomerase (Telomerase Reverse Transcriptase)IBA
10/2002 - 01/2001
3Cathepsin DIBA
10/2001 - 07/2000
3Epidermal Growth Factor Receptor (EGF Receptor)IBA
09/2000 - 07/2000
2Famotidine (Pepcid)FDA LinkGeneric
06/2005 - 06/2005
2PepsinogensIBA
06/2004 - 03/2000
2Vascular Endothelial Growth Factor CIBA
07/2002 - 09/2001
2AntibodiesIBA
03/2002 - 09/2001
2N-methylsuccinimideIBA
11/2001 - 03/2001
2Calcibiotic Root Canal SealerIBA
10/2001 - 01/2000
2telomerase RNA (bTR)IBA
09/2001 - 01/2001
2AnkyrinsIBA
09/2001 - 01/2001
2Nuclear Proteins (Protein, Nuclear)IBA
09/2001 - 01/2001
2Adenosine Diphosphate Ribose (ADP-Ribose)IBA
09/2001 - 01/2001
2glucuronyl glucosamine glycan sulfate (Vessel)IBA
09/2001 - 07/2000
2Interleukin-8 (Interleukin 8)IBA
08/2001 - 07/2000
2Familial primary gastric lymphomaIBA
03/2001 - 03/2001
2Transforming Growth Factor alpha (TGF-alpha)IBA
09/2000 - 08/2000
1Serotonin (5 Hydroxytryptamine)IBA
01/2015
1ramosetron (Nasea)IBA
01/2015
1MicroRNAs (MicroRNA)IBA
10/2013
1rabeprazole (Aciphex)FDA Link
10/2013
1alginic acid (sodium alginate)IBA
07/2012
1Z 338IBA
06/2012
1irsogladineIBA
04/2010
1Immunoglobulin A (IgA)IBA
12/2009
1Carbon MonoxideIBA
06/2007
1Histamine Receptors (Histamine Receptor)IBA
06/2005
1Interleukin-6 (Interleukin 6)IBA
06/2004
1CytokinesIBA
06/2004
13-nitrotyrosineIBA
06/2004
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
06/2004
1BariumIBA
04/2004
1Amoxicillin (Wymox)FDA LinkGeneric
09/2003
1Clarithromycin (Biaxin)FDA LinkGeneric
09/2003
1AcidsIBA
07/2003
1Protective AgentsIBA
07/2003
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
07/2003
1SASIBA
10/2002
1Methylene Blue (Methylthioninium Chloride)FDA Link
08/2002
1Genetic Markers (Genetic Marker)IBA
11/2001
1Proteins (Proteins, Gene)IBA
09/2001
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
09/2001
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
08/2001
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
08/2001
1TrimebutineIBA
08/2001
1VAP-cyclo protocolIBA
06/2001
1AmmoniaIBA
05/2001
1Glucose Transporter Type 1IBA
01/2001
1UreaseIBA
01/2001

Therapy/Procedure

2Intravenous Infusions
06/2005 - 08/2001
1Aftercare (After-Treatment)
04/2010
1Cholecystectomy
08/2001
1Drug Therapy (Chemotherapy)
06/2001